Protein,Protein_definition,Disease_category,Disease,NB_individual,NB_case,OR[95%CI],P_value
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Certain infectious and parasitic diseases,44919,1822,1.11 [0.97-1.27],0.1366898849638926
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit bacterial Sepsis,44182,436,1.64 [1.25-2.14],0.0003267122641154
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Intestinal infectious diseases,49094,334,1.18 [0.87-1.60],0.2926597270399506
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit Sepsis,33927,1595,1.29 [1.12-1.49],0.0005895100675891
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial intestinal infections,48987,227,1.26 [0.87-1.83],0.2135953313175487
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Explicit Sepsis,45800,176,2.15 [1.42-3.27],0.0003367053989329
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial intestinal infections, IBD co-morbidities",51501,225,1.27 [0.88-1.83],0.2089654404800882
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other specified/unspecified bacterial intestinal infections,51506,153,1.09 [0.70-1.70],0.7124874982089315
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Implicit viral Sepsis,44733,118,2.90 [1.74-4.82],4.046807488825697e-05
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial diseases,49811,242,1.87 [1.31-2.66],0.0005555673954757
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other septicaemia,49725,156,2.36 [1.52-3.65],0.0001200785718294
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Viral infections characterized by skin and mucous membrane lesions,51668,136,1.32 [0.82-2.14],0.2530209943214434
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other viral diseases,51660,167,1.39 [0.90-2.14],0.1323288399518578
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Other viral diseases, not elsewhere classified",51647,154,1.47 [0.94-2.30],0.0937580767777329
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Mycoses,50957,105,0.86 [0.50-1.49],0.5974486395769245
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,"Bacterial, viral and other infectious agents",49196,834,1.10 [0.91-1.34],0.3374268279381781
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Streptococcus and staphylococcus as the cause of diseases classified to other chapters,48647,285,1.28 [0.92-1.78],0.1386415034622339
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Other bacterial agents as the cause of diseases classified to other chapters,48935,573,0.99 [0.79-1.25],0.9472824040697746
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of colon, excluding all cancers (controls excluding all cancers)",41411,132,0.59 [0.36-0.96],0.0336531561434802
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant melanoma of skin, excluding all cancers (controls excluding all cancers)",41391,112,1.18 [0.70-2.01],0.532512817809942
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Other malignant neoplasms of skin (=non-melanoma skin cancer), excluding all cancers (controls excluding all cancers)",41810,531,0.96 [0.75-1.23],0.7567104829792533
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Squamous cell neoplasms and carcinomas of the skin, excluding all cancers (controls excluding all cancers)",41827,548,0.94 [0.74-1.20],0.6302644563187637
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of breast, excluding all cancers (controls excluding all cancers)",23433,680,0.86 [0.69-1.08],0.1960518178574598
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Malignant neoplasm of prostate, excluding all cancers (controls excluding all cancers)",18763,237,1.43 [1.00-2.04],0.048749793827108
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Non-Hodgkin lymphoma, all, excluding all cancers (controls excluding all cancers)",41387,108,1.62 [0.95-2.77],0.0760223279532421
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,46135,1600,1.33 [1.15-1.53],9.568621136487214e-05
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm of colon, rectum, anus and anal canal",49078,675,0.83 [0.67-1.03],0.0929107746004977
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Sigmoid colon,50736,237,0.79 [0.55-1.14],0.2074401294372075
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Benign neoplasm: Colon, unspecified",51829,226,0.81 [0.56-1.16],0.2480615690901869
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Rectum,51271,136,0.68 [0.42-1.10],0.1165202948015314
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of other and ill-defined parts of digestive system,51848,137,1.30 [0.81-2.08],0.275980453007259
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm: Stomach,51942,104,1.38 [0.80-2.38],0.242314694524472
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm,51388,599,0.85 [0.68-1.07],0.1680081082374698
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of trunk,51851,221,0.97 [0.67-1.42],0.888963350332018
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign lipomatous neoplasm of skin and subcutaneous tissue of limbs,51861,182,1.11 [0.74-1.68],0.6168047137607314
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma and lymphangioma, any site",51739,104,0.86 [0.50-1.50],0.6020795483319389
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,"Haemangioma, any site",51744,103,0.87 [0.50-1.52],0.629395899230064
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi,51571,397,1.00 [0.75-1.32],0.9778072209992038
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Melanocytic naevi of other and unspecified parts of face,51878,176,0.95 [0.62-1.46],0.8107852608962143
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Other benign neoplasms of skin,51667,365,0.97 [0.72-1.30],0.8191798104004596
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Benign neoplasm of breast,27949,138,1.45 [0.89-2.36],0.1321142393657824
RGMA,Repulsive guidance molecule A,Chapter II Neoplasms,Leiomyoma of uterus,27432,1014,0.85 [0.71-1.02],0.0720545672164758
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified iron deficiency,49307,396,1.20 [0.90-1.59],0.212480708536446
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other anaemias,48650,708,1.40 [1.13-1.73],0.0019784452655755
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Other and unspecified anaemias,48650,708,1.40 [1.13-1.73],0.0019784452655755
RGMA,Repulsive guidance molecule A,Chapter I Certain infectious and parasitic diseases,Condition for Implicit Sepsis (Organ dysfunction codes),44843,940,1.20 [1.00-1.45],0.0486791909033127
RGMA,Repulsive guidance molecule A,Chapter III Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism,Agranulocytosis,50832,140,1.72 [1.07-2.76],0.024328473994611
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of other endocrine glands,51324,170,1.98 [1.30-3.04],0.0016332452819066
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Metabolic disorders,41943,2377,1.03 [0.92-1.17],0.5925569180199646
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of the thyroid gland,48852,1097,1.05 [0.88-1.25],0.5776513662227998
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes,47262,273,9.91 [7.22-13.61],1.216256117551142e-45
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Peripheral artery disease,49546,226,1.37 [0.95-1.98],0.0878164253614517
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 1 diabetes without complications,47235,246,9.74 [6.98-13.60],7.676320696312604e-41
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes,48104,1115,1.56 [1.32-1.85],3.407780034522747e-07
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Type 2 diabetes without complications,48068,1079,1.52 [1.27-1.81],2.763763566921377e-06
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Obesity,48058,371,0.83 [0.61-1.13],0.2350850677969677
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Obesity, other/unspecified",48061,367,0.83 [0.61-1.13],0.2420724237206694
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Disorders of lipoprotein metabolism and other lipidaemias,41594,2028,0.96 [0.84-1.09],0.5327105428270859
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Hyperlipidaemia, other/unspecified",39834,268,0.90 [0.63-1.27],0.5404600209832855
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Pure hypercholesterolaemia,41438,1872,0.98 [0.85-1.12],0.7401896447847554
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases",Volume depletion,39668,102,2.67 [1.54-4.63],0.0004724991109932
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Other disorders of fluid, electrolyte and acid-base balance",39738,172,1.56 [1.02-2.39],0.0409839513741398
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Any mental disorder,43929,1316,0.85 [0.73-1.00],0.0485127780106795
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Substance abuse, excluding more controls",43074,461,0.62 [0.48-0.81],0.0005433693563913
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mental and behavioural disorders due to alcohol, excluding acute intoxication",51125,343,0.58 [0.43-0.79],0.0005145867075119
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol use disorder, ICD-based",51256,248,0.57 [0.40-0.81],0.0017337623219641
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Acute alcohol intoxication,48355,118,0.52 [0.31-0.87],0.0121091168499333
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Acute alcohol intoxication, ICD10",51744,118,0.55 [0.33-0.91],0.0202745643022707
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Alcohol abuse, main dg, excluding more controls",42731,118,0.52 [0.31-0.86],0.0118496647301292
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Alcohol dependence,48378,141,0.66 [0.41-1.06],0.0823820132242549
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Smoking dependency,48265,119,0.80 [0.48-1.34],0.4008900672764173
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Schizophrenia or delusion, excluding more controls",42723,110,1.04 [0.61-1.77],0.8859875972310884
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Mood disorders, excluding more controls",43265,652,0.90 [0.72-1.12],0.3497696686935442
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Depression,48709,571,0.80 [0.63-1.01],0.0625563033088092
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Depression or dysthymia,42752,496,0.77 [0.60-0.99],0.04192969286715
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,"Anxiety disorders, excluding more controls",42870,257,0.83 [0.58-1.17],0.2863424714227679
RGMA,Repulsive guidance molecule A,Chapter V Mental and behavioural disorders,Other anxiety disorders,48993,134,0.85 [0.53-1.38],0.5152551120545397
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Neurological diseases,44400,2974,0.87 [0.78-0.97],0.012532793848371
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other degenerative diseases of the nervous system,40320,268,0.39 [0.27-0.55],1.2418830484936892e-07
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,MS-disease / Multiple Sclerosis,51639,214,0.30 [0.20-0.44],6.844304824478473e-10
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Episodal and paroxysmal disorders,49223,969,0.95 [0.80-1.14],0.6114887472077681
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Epilepsy,48561,307,0.86 [0.62-1.18],0.344424425749808
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Migraine,48415,161,0.98 [0.63-1.53],0.931904300280585
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Migraine, unspecified, drug-induced",51328,146,1.04 [0.65-1.66],0.8750407244818672
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Transient ischemic attack,50251,159,1.22 [0.78-1.88],0.383024744417806
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other sleep disorders,48586,332,0.88 [0.65-1.20],0.4223418176203455
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Sleep apnoea,50777,253,1.00 [0.71-1.41],0.987611962708128
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Nerve, nerve root and plexus disorders",49574,1340,1.11 [0.95-1.30],0.1851173761891904
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,"Other and unspecified nerve root and plexus disorders, also in other diseases",48481,247,1.18 [0.83-1.69],0.3586780185455325
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Carpal tunnel syndrome,49011,777,1.10 [0.90-1.35],0.3437372235617064
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Cerebral palsy and other paralytic syndromes,51325,165,0.33 [0.21-0.50],2.6010836695396976e-07
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Hemiplegia,51274,114,0.37 [0.22-0.62],0.0001399075206311
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Other neurological diseases,50933,248,0.80 [0.56-1.14],0.221087760866567
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of eyelid, lacrimal system and orbit",50590,741,0.89 [0.73-1.10],0.2763363221911399
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of eyelid,50277,428,0.88 [0.67-1.15],0.3369501905063317
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Chalazion,50001,152,0.75 [0.48-1.18],0.2144646667135282
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other specified and unspecified  disorders of eyelid,50090,241,0.82 [0.57-1.17],0.2769686110945826
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of lacrimal system,50007,158,1.28 [0.82-2.00],0.2690958395672121
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Senile cataract,44705,327,1.12 [0.82-1.52],0.4779092851640671
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other cataract,45186,808,1.16 [0.95-1.41],0.1491368526681529
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Disorders of choroid and retina,49901,441,1.79 [1.38-2.32],1.3403141292642849e-05
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Background diabetic retinopathy,51261,106,8.07 [4.97-13.11],3.255099426712225e-17
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diabetic maculopathy,4420,106,6.16 [3.82-9.96],1.0555805750665749e-13
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Diabetic maculopathy, excluding more controls",46947,106,8.89 [5.42-14.59],5.112544135646264e-18
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Glaucoma,50562,193,1.18 [0.79-1.75],0.4239094506034482
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other and unspecified glaucoma,50475,106,1.33 [0.78-2.27],0.2933784049326629
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process","Disorders of ocular muscles, binocular movement, accommodation and refraction",50521,175,0.96 [0.63-1.47],0.8573187379104504
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Visual disturbances,50822,196,1.17 [0.79-1.74],0.4298260222949729
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Diseases of middle ear and mastoid,51714,270,0.80 [0.57-1.12],0.1951849298424228
RGMA,Repulsive guidance molecule A,"Chapter VII Diseases of the eye, adnexa, ear and mastoid process",Other disorders of ear,50170,200,0.94 [0.63-1.40],0.7650597931852643
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Death due to cardiac causes,36774,6622,1.01 [0.93-1.10],0.8113559541112598
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Rheumatic valve diseases,50649,139,0.86 [0.53-1.37],0.5192958591800412
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, essential",38705,4562,1.04 [0.95-1.15],0.3908399117189076
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertension,38772,4629,1.11 [1.01-1.22],0.035959067465454
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypertensive Renal Disease,34303,160,,
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic heart disease, wide definition",47495,2426,1.07 [0.95-1.20],0.2753165769146108
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Angina pectoris,46525,1456,1.05 [0.90-1.22],0.530172017885314
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Unstable angina pectoris,49808,494,1.42 [1.11-1.82],0.0054352121160717
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Major coronary heart disease event,50289,975,1.28 [1.07-1.53],0.0065838873599587
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, with ST-elevation",51665,192,1.53 [1.04-2.26],0.0324549898917489
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Myocardial infarction, strict",45673,604,1.11 [0.89-1.40],0.3504375787078572
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Coronary atherosclerosis,46961,1927,1.06 [0.93-1.21],0.3675033775073277
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Pulmonary embolism,50261,219,1.14 [0.79-1.66],0.4787123436447047
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Venous thromboembolism,50473,461,1.04 [0.80-1.35],0.7563921105244509
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Secondary right heart disease,50224,182,1.18 [0.78-1.79],0.4213274289707015
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other pulmonary heart/vessel disease,50226,184,1.21 [0.80-1.82],0.3696024250653039
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Hypertension, Pulmonary Arterial",34318,175,1.17 [0.76-1.81],0.4718225011648796
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Cardiomyopathy,43036,117,1.23 [0.73-2.06],0.4383363354920561
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Conduction disorders,43167,248,1.12 [0.78-1.60],0.5340386252233715
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Paroxysmal tachycardia,28659,241,1.12 [0.77-1.63],0.5607507743382898
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Atrial fibrillation and flutter,29305,887,1.00 [0.82-1.22],0.997029596748114
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other arrhythmias,43055,136,0.88 [0.54-1.43],0.6040212036079622
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other or ill-defined heart diseases,43107,188,0.99 [0.66-1.49],0.9662361797618249
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Heart failure, strict",49764,419,1.15 [0.88-1.51],0.2998402890306932
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, including SAH",50097,312,1.03 [0.75-1.41],0.8635527087620571
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Stroke, excluding SAH",50167,263,1.01 [0.72-1.42],0.955944970393418
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Ischaemic Stroke, excluding all haemorrhages",50324,232,1.02 [0.71-1.47],0.902716363762772
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other diseases of arteries and capillaries,49542,159,1.16 [0.75-1.81],0.4978959666362664
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Other peripheral vascular diseases,49645,262,1.19 [0.85-1.68],0.3080017491610488
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Phlebitis and thrombophlebitis (not including DVT),48939,285,0.88 [0.63-1.22],0.4384995619307839
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,DVT of lower extremities,48896,242,1.05 [0.74-1.50],0.7939145389849126
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"!Phlebitis/thrombophlebitis venae iliacae [externae/internae/communis], drug-induced",51490,232,1.00 [0.70-1.44],0.9829824396912537
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Varicose veins,49612,958,0.89 [0.74-1.07],0.2229132116434239
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,Hypotension,49484,174,0.80 [0.53-1.23],0.309133953895864
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Diseases of the respiratory system,41399,4158,0.89 [0.81-0.98],0.012884327110038
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Acute upper respiratory infections,51549,216,0.80 [0.55-1.17],0.2437126246239206
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Influenza and pneumonia,48117,456,1.05 [0.81-1.37],0.7119945457754635
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Pneumonia, organism unspecified",48061,400,1.14 [0.86-1.51],0.3582051582169384
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other acute lower respiratory infections,50024,506,0.79 [0.62-1.02],0.0667531246427833
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Unspecified acute lower respiratory infection,50013,495,0.80 [0.62-1.03],0.0845023135660314
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of upper respiratory tract,50304,1231,1.05 [0.89-1.23],0.5870304772257027
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic sinusitis,49263,190,0.80 [0.54-1.21],0.2941503294182953
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Nasal polyp,49323,250,0.99 [0.69-1.40],0.9391490607541952
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified",49861,788,1.02 [0.83-1.24],0.8560890995881044
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Deviated nasal septum,49446,373,1.11 [0.83-1.49],0.463961733806073
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Vocal cord dysfunction,23866,127,0.84 [0.50-1.40],0.5009008345521131
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Chronic lower respiratory diseases,46379,2038,0.80 [0.70-0.90],0.0004083062017631
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Early onset COPD,49534,357,0.65 [0.49-0.88],0.0049497029541508
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"COPD, hospital admissions 1, only main diagnosis",49586,409,0.73 [0.55-0.96],0.0263380869621122
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Other chronic obstructive pulmonary disease, including avohilmo",49586,409,0.73 [0.55-0.96],0.0263380869621122
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, hospital admissions , main diagnosis only",48418,1679,0.78 [0.68-0.90],0.0005337939828522
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Asthma,37051,1679,0.74 [0.64-0.85],3.641143638415976e-05
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, excluding more controls",36509,1679,0.74 [0.64-0.85],3.5025587824968874e-05
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"Asthma, unspecified (mode)",37026,1654,0.74 [0.64-0.86],4.630370936006106e-05
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory diseases principally affecting the interstitium,51176,185,1.04 [0.69-1.56],0.8471030459295162
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Interstitial lung disease,48935,143,0.98 [0.61-1.55],0.9182150943940148
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,"ILD, hospital admissions",51336,143,0.97 [0.61-1.54],0.912654526607268
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Idiopathic pulmonary fibrosis,48921,129,0.74 [0.46-1.21],0.2309867050053595
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Pleural effusion,47716,223,0.89 [0.61-1.30],0.5528228115294516
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other diseases of pleura,47974,481,0.90 [0.69-1.16],0.3966572390270417
RGMA,Repulsive guidance molecule A,Chapter X Diseases of the respiratory system,Other respiratory disorders and diseases,49371,221,0.78 [0.54-1.13],0.1850851909157129
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastrointestinal diseases,35297,11738,0.95 [0.89-1.02],0.1395613155937854
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oral cavity, salivary glands and jaws",50866,850,1.12 [0.92-1.35],0.2673972567126687
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Embedded and impacted teeth,51865,187,1.25 [0.82-1.89],0.2991823533202032
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Impacted teeth,51873,173,1.24 [0.81-1.91],0.3269791550049711
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Dental caries,50235,219,1.24 [0.85-1.80],0.2617905418492711
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of pulp and periapical tissues,50216,200,1.00 [0.67-1.48],0.9809795500280828
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Palatinal maxillary canine,51845,207,1.20 [0.81-1.78],0.3702298054693368
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other disorders of teeth and supporting structures,50213,197,0.89 [0.60-1.33],0.5829609912013481
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of lip and oral mucosa,49676,157,0.93 [0.60-1.46],0.7579952367764896
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oral lichen ruber planus,51703,105,1.15 [0.67-1.97],0.6165293552097613
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastroduodenal ulcer,39470,550,0.98 [0.77-1.25],0.897268496869276
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Diseases of oesophagus, stomach and duodenum",43273,4353,1.00 [0.91-1.09],0.9627879142842084
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophagitis,39598,678,0.94 [0.75-1.16],0.552956805935996
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastro-oesophageal reflux disease,40320,1400,0.90 [0.77-1.05],0.1866671441388552
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of oesophagus,39074,154,1.30 [0.83-2.04],0.2537894003261035
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcer of oesophagus,39336,416,0.90 [0.68-1.18],0.4463311109405269
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Oesophageal obstruction,39034,114,0.74 [0.44-1.24],0.2494390431529622
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Gastric ulcer,39228,308,0.93 [0.67-1.27],0.6378879473889119
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Duodenal ulcer,39170,250,0.98 [0.69-1.39],0.8995110933964965
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Duodenal ulcer - Unspecified as acute or chronic, without haemorrhage or perforation, drug-induced",51654,173,0.96 [0.63-1.46],0.8506936145249994
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Chronic gastritis,39169,249,0.91 [0.64-1.30],0.604034026017066
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other gastritis (incl. Duodenitis),40556,1636,1.04 [0.90-1.20],0.5697696056583942
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of appendix,51611,252,0.80 [0.56-1.14],0.2088234599933636
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Functional dyspepsia,39795,875,1.17 [0.97-1.42],0.1056389130466583
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of stomach and duodenum,39265,345,1.03 [0.76-1.39],0.8542784777475654
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Colonic or urogenital fistula,51603,311,1.30 [0.95-1.78],0.1001801454089968
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute appendicitis,51563,204,0.91 [0.61-1.35],0.6409093554848495
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Hernia,45445,3284,0.83 [0.75-0.92],0.0004573568827136
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Inguinal hernia,43369,1208,0.87 [0.74-1.02],0.0882213202068798
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Umbilical hernia,42422,261,0.93 [0.67-1.31],0.6908687356737574
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ventral hernia,42366,205,0.73 [0.49-1.08],0.112316458178331
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diaphragmatic hernia,43900,1739,0.82 [0.71-0.94],0.0044730625580553
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfective enteritis and colitis,49952,1531,1.36 [1.17-1.57],3.4666433918784994e-05
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestines,40633,4037,0.95 [0.87-1.05],0.3256727766862529
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, all UC cases excluded)",51242,119,1.50 [0.90-2.51],0.1189774696974874
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Crohn disease (strict definition, require KELA, min 2 HDR)",51791,164,1.71 [1.10-2.64],0.0163021736100127
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn disease,48585,164,1.72 [1.11-2.67],0.0148277033684084
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Crohn's disease NAS,48545,124,1.96 [1.19-3.24],0.0086622781718931
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis (strict definition, require KELA, min 2 HDR)",51656,278,2.57 [1.85-3.56],1.7091689828170538e-08
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Ulcerative colitis,48699,278,2.62 [1.88-3.64],1.1803642327608289e-08
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Ulcerative colitis, NAS",48671,250,2.94 [2.08-4.16],1.1226421541132292e-09
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other noninfective gastroenteritis and colitis,49662,1241,1.19 [1.01-1.40],0.0357912750152838
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Noninfectious colitis NAS,49648,1227,1.19 [1.01-1.40],0.0347337857231483
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Paralytic ileus and intestinal obstruction,36799,203,0.98 [0.66-1.46],0.935134276579824
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal stricture,50994,203,0.99 [0.67-1.47],0.9626107563371448
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Other or unspecified ileus, impaction or obstruction",36730,134,0.89 [0.54-1.44],0.6265360805119617
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diverticular disease of intestine,37814,1218,0.84 [0.72-1.00],0.0462150508828187
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Irritable bowel syndrome,36930,334,0.82 [0.60-1.12],0.2069940496722021
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other functional intestinal disorders,37178,582,1.06 [0.83-1.34],0.6514279128035763
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Constipation,48616,522,1.16 [0.91-1.49],0.2366199416602846
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of peritoneum,51013,183,0.92 [0.61-1.40],0.7116001078187228
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Fissure and fistula of anal and rectal regions,36881,285,1.36 [0.98-1.90],0.0686270151840909
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Abscess of anal and rectal regions,36738,142,1.33 [0.83-2.13],0.2293274753824112
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of anus and rectum,38369,1773,0.88 [0.77-1.01],0.0676114856707988
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of intestine,37147,551,1.02 [0.80-1.29],0.8886673545583339
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of peritoneum,50984,154,0.76 [0.48-1.19],0.2332393843013449
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of liver,50279,250,1.59 [1.12-2.25],0.0089716797343941
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of liver,50166,137,1.42 [0.89-2.26],0.1453332403729551
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Disorders of gallbladder, biliary tract and pancreas",49160,1266,0.92 [0.79-1.09],0.3400207596799818
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholelithiasis,48912,1018,0.84 [0.70-1.00],0.0566470826571764
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Cholecystitis,48093,199,1.01 [0.68-1.50],0.9665833858904764
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of biliary tract,47998,104,1.93 [1.12-3.33],0.0176455471240771
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis,48032,138,1.41 [0.88-2.26],0.1496098357943103
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Acute pancreatitis (for exclusion),51573,138,1.41 [0.88-2.25],0.1500153798328407
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Diseases of the digestive system,49122,637,0.99 [0.79-1.24],0.9306380011233476
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Intestinal malabsorption,48629,144,1.30 [0.81-2.09],0.2686720791265046
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Coeliac disease,48603,118,1.24 [0.73-2.08],0.4252669443737804
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,"Postprocedural disorders of digestive system, not elsewhere classified",48585,100,0.75 [0.43-1.32],0.320813174703431
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,Other diseases of the digestive system,48889,404,0.90 [0.68-1.19],0.4595625900013182
RGMA,Repulsive guidance molecule A,Chapter XI Diseases of the digestive system,GI-bleeding,48875,390,0.90 [0.68-1.20],0.4741705963940075
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Diseases of the skin and subcutaneous tissue,45530,3133,1.04 [0.94-1.15],0.4834029846724158
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Dermatitis and eczema,51008,209,0.83 [0.57-1.22],0.3511352144757569
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Disorders of skin appendages,51075,913,1.03 [0.85-1.24],0.7625502486051903
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other disorders of skin and subcutaneous tissue,48694,1169,1.18 [1.00-1.40],0.0453959543888092
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Infections of the skin and subcutaneous tissue,50073,793,0.90 [0.73-1.09],0.2802586184514151
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Cutaneous abscess, furuncle and carbuncle",49455,175,0.99 [0.65-1.51],0.9723713495638934
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Cellulitis,49791,511,1.06 [0.83-1.36],0.6307875579430176
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Papulosquamous disorders,51364,185,1.07 [0.71-1.60],0.7503623611518867
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Psoriasis,51323,144,0.95 [0.60-1.50],0.8167121245213359
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified psoriasis,51289,110,0.98 [0.58-1.65],0.9279930854620496
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Radiation-related disorders of the skin and subcutaneous tissue,51323,114,1.05 [0.62-1.77],0.8611380316858834
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Skin changes due to chronic exposure to nonionizing radiation,51318,109,1.04 [0.61-1.77],0.8993906022569353
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Nail disorders,50272,110,0.74 [0.44-1.27],0.2759000146568517
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Follicular cysts of skin and subcutaneous tissue,50895,733,1.14 [0.92-1.40],0.2283092831657571
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Seborrhoeic keratosis,47711,186,0.73 [0.48-1.11],0.1376233532019545
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Atrophic disorders of skin,47729,204,1.50 [1.01-2.23],0.0429136030046472
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Scar conditions and fibrosis of skin,47680,155,1.13 [0.71-1.77],0.6098362921250271
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,"Other disorders of skin and subcutaneous tissue, not elsewhere classified",47968,443,1.14 [0.87-1.49],0.3269662221924718
RGMA,Repulsive guidance molecule A,Chapter XII Diseases of the skin and subcutaneous tissue,Other and unspecified disorders of skin and subcutaneous tissue,47922,397,1.27 [0.95-1.68],0.1024353773709818
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Diseases of the musculoskeletal system and connective tissue,37403,8066,1.00 [0.93-1.07],0.9449689728302078
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthropathies,40645,4686,0.99 [0.90-1.08],0.7920230406317919
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Soft tissue disorders,46800,2439,1.02 [0.91-1.15],0.6785037099905185
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rheumatoid arthritis,36260,301,1.03 [0.75-1.43],0.8475554351874299
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthropathies,36897,938,1.00 [0.83-1.21],0.9714185929607938
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other (seronegative) rheumatoid arthritis, wide",51070,289,1.05 [0.76-1.47],0.7554988747219417
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified rheumatoid arthritis,51092,261,1.06 [0.75-1.49],0.7604461368807317
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Arthrosis,38283,2324,0.89 [0.79-1.01],0.0693165672467189
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Artrosis, including avohilmo",43478,2324,0.90 [0.79-1.01],0.0723833261545578
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gout,36101,142,0.88 [0.55-1.39],0.5773543948789557
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Gout, unspecified",50760,138,0.88 [0.55-1.40],0.5839352269731931
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified arthritis,36410,451,0.93 [0.71-1.21],0.5759760735938508
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Polyarthrosis,36103,144,0.76 [0.48-1.22],0.253931581592424
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Coxarthrosis,36525,566,0.67 [0.53-0.85],0.000983937426011
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Coxarthrosis, primary",51598,279,0.79 [0.57-1.11],0.1758099011075623
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Gonarthrosis,37030,1071,0.92 [0.77-1.10],0.3462227930537905
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other arthrosis,36760,801,1.03 [0.84-1.26],0.8024713827549426
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other joint disorders,38571,2612,1.05 [0.94-1.18],0.4167764020973635
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other deformities of toe(s),36091,132,0.91 [0.55-1.50],0.7120843547992468
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux valgus (acquired),36436,477,0.90 [0.69-1.17],0.4372785118672974
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Hallux rigidus,36073,114,1.32 [0.78-2.25],0.3024183597607591
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other hammer toe(s) (acquired),36081,122,0.57 [0.34-0.96],0.0341090688081709
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Internal derangement of knee,36939,980,1.19 [0.99-1.43],0.0589619315707656
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Meniscus derangement,36806,847,1.19 [0.98-1.44],0.0859898759408987
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in joint,40182,564,0.93 [0.74-1.18],0.5610568817182016
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Systemic lupus erythematosus,50791,257,2.61 [1.85-3.69],5.5512389497737255e-08
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other systemic involvement of connective tissue,50647,113,2.18 [1.29-3.69],0.0034423466988984
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Deforming dorsopathies,44882,128,0.81 [0.49-1.33],0.4003013440063925
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylopathies,45352,598,1.01 [0.81-1.27],0.9154531387781673
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Dorsopathies,46633,1879,0.91 [0.80-1.04],0.1809916689718694
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spondylosis,45135,381,0.89 [0.67-1.18],0.405316691183672
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Spinal stenosis,44928,174,1.17 [0.77-1.78],0.452766425568747
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other dorsopathies, not elsewhere classified",46232,1478,0.94 [0.81-1.09],0.389217534789976
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervical disc disorders,44857,103,0.84 [0.48-1.46],0.536234388147057
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other intervertebral disc disorders,45228,474,1.01 [0.78-1.30],0.9504364855320544
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Lumbar disc prolapse,44959,205,1.21 [0.82-1.80],0.3309971550493744
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Sciatica+with lumbago,44913,159,0.94 [0.60-1.46],0.7701920151327193
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified dorsalgia,45039,285,0.88 [0.63-1.22],0.4389254597859261
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Cervicalgia,44880,126,0.63 [0.38-1.04],0.0700172352561014
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Low back pain,45371,617,0.99 [0.79-1.24],0.9306673535023616
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of synovium and tendon,44990,629,1.17 [0.94-1.47],0.1627899708598391
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other/unspecified synovitis and tenosynovitis,44499,138,0.68 [0.42-1.09],0.111958639931942
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Trigger finger,44536,175,1.70 [1.11-2.58],0.0136283517116488
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Ganglion,44566,205,1.15 [0.77-1.70],0.4982938357218025
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Soft tissue disorders related to use, overuse and pressure",44461,100,0.69 [0.40-1.22],0.2015586524501691
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Fibroblastic disorders,44595,234,0.59 [0.41-0.84],0.0041697048778121
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Palmar fascial fibromatosis [Dupuytren],44568,207,0.59 [0.40-0.87],0.0077428940579864
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Shoulder lesions,44898,537,0.98 [0.77-1.25],0.8793198784550489
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other shoulder lesions,44474,113,1.05 [0.62-1.78],0.8472711195032894
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Rotator cuff syndrome,44518,157,0.74 [0.47-1.15],0.1796929342119277
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Impingement syndrome of shoulder,44617,256,0.76 [0.53-1.08],0.1200593272041078
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other enthesopathies,44484,123,1.51 [0.91-2.50],0.1107111628554295
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,"Other soft tissue disorders, not elsewhere classified",45255,894,1.04 [0.86-1.26],0.6890058835376203
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified soft tissue disorders,44699,338,0.98 [0.72-1.33],0.8994666988893594
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Pain in limb,44841,480,1.14 [0.88-1.47],0.3240839076440115
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteoporosis,48098,347,1.08 [0.80-1.45],0.6377629103643627
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Osteopathies and chondropathies,48538,787,1.09 [0.89-1.33],0.3959457158352949
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Disorders of continuity of bone,47849,98,0.91 [0.52-1.61],0.7541706474545039
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other specified/unspecified disorders of  bone/cartilage,47868,117,0.86 [0.51-1.45],0.5726077168144574
RGMA,Repulsive guidance molecule A,Chapter XIII Diseases of the musculoskeletal system and connective tissue,Other disorders of bone,47956,205,1.09 [0.73-1.61],0.6825674417499198
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Genitourinary diseases,41178,8593,1.08 [1.01-1.16],0.0227683046597327
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Diseases of male genital organs,20606,1288,1.14 [0.97-1.33],0.1073271622714588
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Renal tubulo-interstitial diseases,46597,509,8.50 [6.68-10.81],4.788186991616365e-68
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other obstructive and reflux uropathy,46225,137,2.75 [1.71-4.44],3.1693358915208057e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Acute renal failure,46803,111,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Chronic kidney disease,46830,138,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified kidney failure,46828,136,,
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urolithiasis,51172,494,1.12 [0.88-1.44],0.3636932856146184
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of kidney and ureter,51016,144,3.24 [2.07-5.08],3.001744068917993e-07
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Calculus of kidney and ureter,51034,356,1.19 [0.89-1.59],0.2476668028940361
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified renal colic,50849,171,1.03 [0.67-1.56],0.9042364918871026
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other diseases of urinary system,47424,2121,1.04 [0.92-1.18],0.5316265204784907
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Cystitis,45501,198,1.46 [0.98-2.18],0.0632001447077159
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Neuromuscular dysfunction of bladder,45465,162,0.76 [0.49-1.19],0.2318402715772667
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of  bladder,45863,560,1.13 [0.89-1.43],0.3009435967942236
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Urethral stricture,45534,231,1.12 [0.78-1.61],0.5533876601486143
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of urethra and urinary system,46682,1379,1.00 [0.86-1.17],0.9948947890803174
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hyperplasia of prostate,19889,571,1.06 [0.84-1.35],0.6022263162426766
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of prostate (prostatitis),19425,107,1.46 [0.86-2.47],0.1585430647462394
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Hydrocele,19420,102,1.29 [0.75-2.21],0.3577446214163652
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Redundant prepuce, phimosis and paraphimosis",19482,164,1.18 [0.77-1.81],0.4476320808678733
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of penis,19477,159,1.01 [0.65-1.56],0.9742620079712788
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of male genital organs,19536,218,1.23 [0.85-1.79],0.2698207947390497
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Disorders of breast,27686,483,0.91 [0.70-1.19],0.4991458586290612
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Benign mammary dysplasia,27352,149,0.99 [0.62-1.57],0.9501791188689565
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified lump in breast,27373,170,0.91 [0.59-1.41],0.6811496130128684
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other disorders of breast,27317,114,1.07 [0.63-1.82],0.8095104438171064
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory diseases of female pelvic organs,27622,567,1.01 [0.80-1.29],0.9172678277318348
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Inflammatory disease of cervix uteri,27189,134,1.10 [0.67-1.80],0.7062144775341217
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other female pelvic inflammatory diseases,27309,254,0.92 [0.64-1.32],0.6641603834306219
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Noninflammatory disorders of female genital tract,25525,4650,0.82 [0.75-0.90],3.539155713432932e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Endometriosis,21242,367,0.60 [0.45-0.82],0.0011179342507968
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Unspecified/other endometriosis,20972,97,1.00 [0.56-1.79],0.996170992945378
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Adenomyosis (Endometriosis of uterus),21045,170,0.42 [0.27-0.65],8.784977186990524e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female genital prolapse,21681,806,0.67 [0.54-0.82],0.0001121597361625
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Ovarian cyst,21290,415,0.75 [0.56-0.99],0.0440453244164632
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Polyp of the female genital tract,21847,972,0.78 [0.64-0.94],0.0087117321497055
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Uterine polyps,21197,322,0.80 [0.58-1.10],0.1717540051357946
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Other noninflammatory disorders of uterus, except cervix",21322,447,0.74 [0.57-0.98],0.0328377444901764
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Erosion and ectropion of cervix uteri,20977,102,0.85 [0.48-1.51],0.5855409328231691
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Dysplasia of cervi uteri,21065,190,1.30 [0.86-1.97],0.2180348060853635
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"All dysplastic lesions of the cervix uteri, vagina or vulva",27964,269,1.37 [0.96-1.94],0.0797060722985724
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,All dysplastic lesions of the cervix uteri,27976,255,1.33 [0.93-1.90],0.1240095270827564
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,HSIL lesion of the cervix uteri,28002,142,1.62 [1.00-2.61],0.050301752135915
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"HSIL lesion of the cervix uteri, vagina or vulva",27991,156,1.55 [0.98-2.44],0.0625206274883428
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of cervix uteri,21024,149,0.77 [0.48-1.23],0.2692589000158409
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vagina,20991,116,0.84 [0.49-1.43],0.5143147490034274
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other noninflammatory disorders of vulva and perineum,21021,146,0.82 [0.51-1.32],0.4165648610711248
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Irregular menses,27894,471,0.83 [0.63-1.08],0.157276307839822
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Excessive, frequent and irregular menstruation",22232,1357,0.72 [0.61-0.85],7.305908295740225e-05
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Menorrhagia,21759,884,0.66 [0.54-0.81],4.817717338238815e-05
RGMA,Repulsive guidance molecule A,"Chapter IV Endocrine, nutritional and metabolic diseases","Polycystic ovarian syndrome, consortium definition",27981,197,1.08 [0.72-1.62],0.7165028684766346
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Other abnormal uterine and vaginal bleeding,21348,473,0.81 [0.62-1.06],0.1247442716349423
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Pain and other conditions associated with female genital organs and menstrual cycle,21206,331,0.88 [0.64-1.20],0.416578316157803
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Postmenopausal bleeding,21780,905,0.84 [0.69-1.02],0.0750968926683979
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,Female infertility,20992,117,1.01 [0.59-1.75],0.9628791358917544
RGMA,Repulsive guidance molecule A,Chapter XIV Diseases of the genitourinary system,"Female infertility, cervigal, vaginal, other or unspecified origin",20985,110,1.02 [0.58-1.79],0.9394872998407868
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care related to the fetus and amniotic cavity and possible delivery problems,27998,890,0.84 [0.68-1.05],0.123412436840663
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Complications of labour and delivery,28004,1214,0.74 [0.61-0.89],0.0020365665159618
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy with abortive outcome,27999,484,0.63 [0.48-0.83],0.0008980028997768
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Other abnormal products of conception,27653,138,0.64 [0.39-1.07],0.0897256044081848
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Spontaneous abortion,27708,193,0.63 [0.41-0.97],0.0379199756353557
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Medical abortion,27682,167,0.50 [0.32-0.79],0.0027455497939979
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Oedema, proteinuria and hypertensive disorders in pregnancy, childbirth and the puerperium",28018,167,0.96 [0.61-1.51],0.8507936784093382
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Pregnancy hypertension,28020,164,0.99 [0.62-1.56],0.9491630501219048
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Other maternal disorders predominantly related to pregnancy,28015,424,0.69 [0.51-0.92],0.0126358859169162
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Haemorrhage in early pregnancy,27718,127,0.87 [0.52-1.46],0.5975245333643738
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other conditions predominantly related to pregnancy,27825,234,0.67 [0.45-1.00],0.0473308313004378
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected malpresentation of fetus,27258,150,0.49 [0.30-0.81],0.005310268901135
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for known or suspected abnormality of pelvic organs,27311,203,0.85 [0.56-1.30],0.4508822669704894
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Maternal care for other known or suspected fetal problems,27363,255,0.82 [0.56-1.19],0.2950612751810516
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Premature rupture of membranes,27259,151,0.89 [0.55-1.46],0.6552855829630335
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",False labour,27247,139,0.83 [0.50-1.38],0.4796898016204648
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Prolonged pregnancy,27261,153,0.60 [0.37-0.97],0.0380712459241099
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Long labour,27024,234,0.79 [0.53-1.17],0.2368141272506814
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Labour and delivery complicated by fetal stress [distress],27231,441,0.78 [0.58-1.04],0.0933516733655254
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Perineal laceration during delivery,27470,680,0.74 [0.57-0.95],0.0167324740865725
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Postpartum hemorraghe, all women as controls",28020,173,0.63 [0.40-1.00],0.0476244951659325
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Postpartum haemorrhage due to anatomy,26544,132,0.66 [0.39-1.11],0.1161973448200176
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Other complications of labour and delivery, not elsewhere classified",26895,105,0.78 [0.44-1.41],0.4202676235722495
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Delivery,28028,349,0.78 [0.56-1.07],0.1269459095975401
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium",Single spontaneous delivery,27945,266,0.76 [0.52-1.10],0.1427624918941458
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Other obstetric conditions, not elsewhere classified",28016,257,0.89 [0.61-1.30],0.5420843187764177
RGMA,Repulsive guidance molecule A,"Chapter XV Pregnancy, childbirth and the puerperium","Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium",28006,247,0.87 [0.59-1.27],0.4713077154522592
RGMA,Repulsive guidance molecule A,Chapter IX Diseases of the circulatory system,"Bradycardia, unspecified, drug-induced",51127,123,0.74 [0.45-1.21],0.2305203116310412
RGMA,Repulsive guidance molecule A,Chapter VI Diseases of the nervous system,Falls/tendency to fall,46797,1207,0.74 [0.63-0.87],0.0003319773869906
